Polyclonal Rabbit anti‑Human CCND1 / Cyclin D1 Antibody (FITC, aa1‑30, WB) LS‑C535353
Polyclonal Rabbit anti‑Human CCND1 / Cyclin D1 Antibody (FITC, aa1‑30, WB) LS‑C535353
Antibody:
CCND1 / Cyclin D1 Rabbit anti-Human Polyclonal (aa1-30) (FITC) Antibody
Overview
Antibody:
CCND1 / Cyclin D1 Rabbit anti-Human Polyclonal (aa1-30) (FITC) Antibody
Specifications
Description
Cyclin D1 antibody LS-C535353 is an FITC-conjugated rabbit polyclonal antibody to human Cyclin D1 (CCND1) (aa1-30). Validated for ELISA and WB.
Target
Human CCND1 / Cyclin D1
Synonyms
CCND1 | B-cell lymphoma 1 protein | BCL-1 oncogene | B-cell CLL/lymphoma 1 | BCL-1 | Cyclin D1 | G1/S-specific cyclin-D1 | U21B31 | PRAD1 | BCL1 | D11S287E | PRAD1 oncogene
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
FITC.
Also available conjugated with
APC,
Biotin,
HRP,
PE.
Purification
Ammonium sulfate precipitation
Specificity
This CCND1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human CCND1.
Applications
- Western blot
- ELISA
- Applications tested for the base form of this product only
Presentation
PBS, pH 7.2, No preservatives added
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human, Mouse
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, IHC - Frozen, ICC, Western blot
Species:
Human, Mouse, Rat
Applications:
Western blot
Species:
Human
Applications:
Western blot, Immunoprecipitation, ELISA
Species:
Human, Monkey, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Flow Cytometry
Species:
Human, Mouse, Rat
Applications:
Immunoprecipitation
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/18/2024